Menovazin - vishfa
Ukraine
Table of Contents
INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT MENOVASIN-VISHPHA (MENOVASINUM-VISHPHA)
Composition:
Active substances: menthol, novocaine (procaine hydrochloride), anestezin (benzocaine);
100 ml of solution contains racemic menthol — 2.5 g, procaine hydrochloride — 1 g, benzocaine — 1 g;
Excipient: ethanol 70%.
Pharmaceutical form. Topical solution, alcoholic.
Main physicochemical properties: clear colorless liquid with a menthol odor.
Pharmacotherapeutic group.
Agents used locally for joint and muscular pain.
ATC code M02AX.
Pharmacological properties.
Pharmacodynamics.
The medicinal product has anti-itching action and local anesthetic effect. When applied to the skin and mucous membranes, it causes irritation of nerve endings, accompanied by sensations of cold, mild burning, and tingling.
Exerts mild analgesic action.
Pharmacokinetics.
When applied locally, the medicinal product does not enter the bloodstream.
Clinical characteristics.
Indications.
The medicinal product is indicated for neuralgias, myalgias, and arthralgias.
Contraindications.
The medicinal product is contraindicated in case of hypersensitivity to procaine and other components of the product.
Special precautions.
Do not apply to damaged skin or skin with signs of allergy. Do not apply to facial skin.
The instructions for use of the medicinal product must not be violated — this may harm health.
Interaction with other medicinal products and other forms of interaction.
Components of the medicinal product (procaine, anesthesin) reduce the antibacterial effect of sulfonamides and enhance the effects of agents with local anesthetic action.
When using any other medicinal products simultaneously, inform your doctor.
Special precautions.
Use during pregnancy or breastfeeding.
The use of the medicinal product during pregnancy and breastfeeding is possible only when the expected benefit to the mother outweighs the potential risk to the fetus or infant.
Ability to affect reaction speed when driving or operating machinery.
No effect.
Method of Administration and Dosage.
The medicinal product is intended for topical use. Painful areas of the skin are rubbed with Menovazin-Vishfay solution 2–3 times a day. The duration of treatment depends on the form and severity of the disease, the drug's effect, and the treatment regimen (monotherapy or use in combination with other medicinal products).
Children.
Not recommended for children under 12 years of age.
Overdose.
With prolonged use, dizziness, general weakness, decreased arterial pressure, and allergic reactions are possible. If such symptoms occur, discontinue use of the medicinal product, wash off any residue from the skin surface with water, and administer symptomatic therapy.
Side effects.
Allergic reactions are possible (hyperemia, skin irritation, itching, rash, swelling, urticaria).
If any adverse events occur, consult a physician immediately!
Shelf life. 3 years.
The medicinal product must not be used after the expiry date stated on the packaging.
Storage conditions.
Store at a temperature not exceeding 25 ºC in a place inaccessible to children.
Packaging. 40 ml or 100 ml in glass bottles; 100 ml in polymer bottles.
Dispensing category. Over-the-counter.
Manufacturer.
LLC "DKP "Pharmaceutical Factory".
Manufacturer's address and place of business.
4, Korolyova St., Stanishevska village, Zhytomyr district, Zhytomyr region, 12430, Ukraine.